Our company engagement

As a long-term investor, we engage in regular  dialogue with the companies we invest in. The aim is both to provide support and to communicate our views as an investor. 

Meetings where we discussed consumer interests in 2022 by sector

Meetings where we discussed data privacy in 2022 by sector


Thematic dialogues

We conduct targeted engagements with companies on material sustainability issues using our expectation documents as the point of departure. We typically select groups of companies in industries exposed to specific and severe sustainability risks or opportunities. 

Thematic dialogues related to consumer interests

Themes Companies Progress/examples
Responsible marketing of infant formula 13 consumer companies Nestlé SA, Danone SA and Reckitt Benckiser Group PLC publish reports on
responsible marketing of infant formula that describe the implementation of
their policies and compliance monitoring.
Management of risks related to child safety online 10 telecoms companies BT Group PLC focuses on creating services that are safe for children rather
than solely taking down content that is deemed harmful after it is already
published. They are also rolling out a bespoke human rights training
programme.


Our voting

Our voting at companies' annual shareholder meeting plays an important role in sageguarding the fund's assets. When voting at shareholder meetings, we consider whether the board operates effectively and whether our shareholder rights are adequately protected.

Selected shareholder proposals related to consumer interests

Year Company Proposal Mgmt rec Our vote
2023 Amazon.com Inc Commission Third Party Study and Report on Risks Associated with Use of Rekognition  Against For
2023 Alphabet Inc Report on Alignment of YouTube Policies With Online Safety Regulations Against For
2023 Alphabet Inc Disclose More Quantitative and Qualitative Information on Algorithmic Systems Against For
2023 Meta Platforms Inc Report on Human Rights Impact Assessment of Targeted Advertising Against For
2023 Abbvie Inc Report on Impact of Extended Patent Exclusivities on Product Access Against For
2023 Regeneron Pharmaceuticals Inc Report on Impact of Extended Patent Exclusivities on Product Access Against For

 

Responsible investment in 2022

Further details on our engagement across ESG is also available in our Responsible investment report.